Author

K. Takagi

h-index 0 View on Semantic Scholar

We have 3 of 32 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Recurrence of cardiovascular events despite achieving LDL-C <1.4 mmol/L i in patients with coronary artery disease

The current ESC/EAS guideline recommends lowering LDL-C <1.4 mmol/L for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD) in very high-risk patients. However, despite favourable LDL-C control, atherosclerosis still continues to progress, which eventually causes cardiovascular events. Ther...

Y. Kataoka, S. Nicholls, S. Kitahara et al. · European Heart Journal · 0 citations

Open access Oct 2026

Circulating angiopoietin-like protein 3 levels and subsequent cardiovascular outcomes in patients with coronary artery disease

An increased risk of cardiovascular events was observed in patients with CAD who exhibited ANGPTL3> 363.4 ng/mL, and the findings suggest circulating ANGPTL3 as a potential therapeutic target to further mitigate subsequent cardiovascular events’ risks in patients with CAD.

S. Fujita, Y. Kataoka, N. Kuyama et al. · European Heart Journal · 0 citations

Open access Oct 2026

Clinical impact of more than 50% reduction in low-density lipoprotein cholesterol at 6 weeks after percutaneous coronary intervention for acute coronary syndrome

Early intensive lipid-lowering therapy is recommended after acute coronary syndrome (ACS), and current guidelines recommend assessing attainment of lipid-lowering targets within 4–6 weeks; however, the prognostic significance of achieving a more than 50% reduction in low-density lipoprotein cholesterol (LDL-C) sh...

K. Murai, K. Mitsui, T. Iwai et al. · European Heart Journal · 0 citations